Physical Therapy for Hypertensive Elderly

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-03-31

Study Completion Date

2005-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Physical therapy for hipertensive elderly: effects in the physical activity and exercise adherence.

Introduction: The arterial hypertension (AH) is a clinical syndrome characterized by blood pressure ≥ 140/90mmHg. Practical of physical activity (PA) and/or physical exercise (PE) is one of the modalities of not farmacological treatment. Hypertensive aged not adhere to this recommendation for presenting factors that make it difficult this practical. Objective: to verify if physical therapy (PT) treatment can improve the AF and EF adhesion of hypertensive aged. Methods: The sample was composed by 43 hypertensive aged of Arterial Hypertensive League of the Federal University of Goiás. Of these, 30 had remained in the study and had been randomized in study group (SG) (16 patients) and control group (CG) (14 patients). SG was submitted of the PT treatment and participated of educative meetings, the CG only participated of the meetings. To evaluate adhesion to the AF was used the pedometer and EF was used a questionnaire of open and closed questions, six minute walk test (6'WT) and ergometric test (ET).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Physical therapy hypertension aged exercise Physical exercise Physical activity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

Group Type EXPERIMENTAL

Physical Therapy and education meetings

Intervention Type OTHER

Physical therapy was realized three two times per week and education meeting every fifteen days

Control group

Group Type ACTIVE_COMPARATOR

education meetings

Intervention Type OTHER

This group only participed of education meeting (every fifteen days)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physical Therapy and education meetings

Physical therapy was realized three two times per week and education meeting every fifteen days

Intervention Type OTHER

education meetings

This group only participed of education meeting (every fifteen days)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age or over 60 years,
* both sexes,
* regular frequency of hypertension league;
* practice of physical exercise irregular or absent (reported by professionals objectively on the record)and signature of informed consent. -

Exclusion Criteria

* participate in another research project;
* refuse to sign the informed consent.

Minimum Eligible Age

60 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.